OVARY CANCER
Clinical trials for OVARY CANCER explained in plain language.
Never miss a new study
Get alerted when new OVARY CANCER trials appear
Sign up with your email to follow new studies for OVARY CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo drug trial for Tough-to-Treat ovarian cancer halted
Disease control TerminatedThis early-stage trial tested the safety and best dose of a new drug, STRO-002, when given with an existing cancer drug, bevacizumab. It was for people with advanced ovarian, fallopian tube, or primary peritoneal cancer that had come back or stopped responding to standard treatme…
Matched conditions: OVARY CANCER
Phase: PHASE1 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Early cancer drug trial halted before key testing phase
Disease control TerminatedThis early-stage study tested a new oral cancer drug called NUV-868, both alone and combined with existing medications (olaparib or enzalutamide), in adults with advanced solid tumors. The trial aimed to find safe doses and see if these treatments could help control cancers that …
Matched conditions: OVARY CANCER
Phase: PHASE1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC